These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36361834)
1. Losartan Potassium and Verapamil Hydrochloride Compound Transdermal Drug Delivery System: Formulation and Characterization. Chen YS; Sun YY; Qin ZC; Zhang SY; Chen WB; Liu YQ Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361834 [TBL] [Abstract][Full Text] [Related]
2. Establishment and Validation of a Transdermal Drug Delivery System for the Anti-Depressant Drug Citalopram Hydrobromide. Sun YY; Ni YJ; Wang RJ; Qin ZC; Liu Z; Xiao LH; Liu YQ Molecules; 2024 Feb; 29(4):. PubMed ID: 38398519 [TBL] [Abstract][Full Text] [Related]
3. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system. Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of a losartan potassium released from a transdermal therapeutic system for the treatment of hypertension. Shams MS; Alam MI; Ali A; Sultana Y; Aqil M; Shakeel F Pharmazie; 2010 Sep; 65(9):679-82. PubMed ID: 21038845 [TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of patches for transdermal delivery of losartan potassium. Baviskar DT; Parik VB; Gupta HN; Maniyar AH; Jain DK PDA J Pharm Sci Technol; 2012; 66(2):126-35. PubMed ID: 22492598 [TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of 1-deoxynojirimycin sustained-release delivery system: In vitro and in vivo characterization studies. Chen YS; Jiang X; Sun YY; Zhang SY; Li K; Chen WB; Liu YQ J Biomed Mater Res A; 2021 Nov; 109(11):2294-2305. PubMed ID: 33942484 [TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Kusum Devi V; Saisivam S; Maria GR; Deepti PU Drug Dev Ind Pharm; 2003 May; 29(5):495-503. PubMed ID: 12779279 [TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system. Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo assessment of matrix type transdermal therapeutic system of labetalol hydrochloride. Mittal A; Parmar S; Singh B Curr Drug Deliv; 2009 Oct; 6(5):511-9. PubMed ID: 19863491 [TBL] [Abstract][Full Text] [Related]
10. [Preparation of transdermal drug delivery system of felodipine-metoprolol and its bioavailability in rabbits]. Wang WG; Yun LH; Wang R; Fu GY; Liu ZY Yao Xue Xue Bao; 2007 Nov; 42(11):1206-14. PubMed ID: 18300480 [TBL] [Abstract][Full Text] [Related]
11. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation. Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115 [TBL] [Abstract][Full Text] [Related]
12. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol. Gao Y; Liang J; Liu J; Xiao Y Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930 [TBL] [Abstract][Full Text] [Related]
13. Formulation and Pharmacokinetic Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Koumine. Su Y; Lu W; Fu X; Xu Y; Ye L; Yang J; Huang H; Yu C AAPS PharmSciTech; 2020 Oct; 21(8):297. PubMed ID: 33099696 [TBL] [Abstract][Full Text] [Related]
14. Formulation and Pharmacokinetic Evaluation of Ethyl Cellulose/HPMC-Based Oral Expandable Sustained Release Dosage of Losartan Potassium. Wani TU; Fazli AA; Raza SN; Khan NA; Sheikh FA AAPS PharmSciTech; 2022 Jun; 23(5):160. PubMed ID: 35676602 [TBL] [Abstract][Full Text] [Related]
15. Losartan potassium sustained release pellets with improved Abou Obaid NI; Al-Jenoobi FI; Ibrahim MA; Alam MA Pharm Dev Technol; 2020 Nov; 25(9):1031-1042. PubMed ID: 32538215 [TBL] [Abstract][Full Text] [Related]
16. Transdermal Drug Delivery System of Linagliptin Sustained-release Microparticle Gels: Liu J; Guo S; Hong S; Piao J; Piao M Curr Drug Deliv; 2024; 21(11):1537-1547. PubMed ID: 38243939 [TBL] [Abstract][Full Text] [Related]
17. Role of sodium l-cysteine alginate conjugate and isopropyl myristate to enhance the permeation enhancing activity of BCS class III drug from TDDS; optimization by central composite design and Sadashivaiah R; Babu BKS Drug Dev Ind Pharm; 2020 Sep; 46(9):1427-1442. PubMed ID: 32623912 [TBL] [Abstract][Full Text] [Related]
18. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies. Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361 [TBL] [Abstract][Full Text] [Related]
19. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment. Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906 [TBL] [Abstract][Full Text] [Related]